Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6420d04b0d68f339771080e32bd0fbc9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366 |
filingDate |
2001-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1a81e86ddf54f7f01594bddc266d9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c15af03d457ab90809a68be52f2ba1c |
publicationDate |
2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006286614-A1 |
titleOfInvention |
Method for monitoring coagulability and hypercoagulable states |
abstract |
The assay of soluble endothelial protein C receptor (sEPCR) is useful to monitor effective thrombin levels and a hypercoagulable state. An assay for sEPCR is therefore useful to monitor ongoing effectiveness of anticoagulant therapy. A sEPCR ELISA assay is particularly useful for this purpose. A state of hypercoagulability in patients or normal individuals can also be identified by such an assay. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020147264-A1 |
priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |